Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$8.02
−0.69%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
53.08x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.47x
Price / sales
8179.77x
Price / cash flow
-12.20x

Enterprise value

Enterprise value
$64.1M
EV / sales
4664.17x
EV / EBITDA
-5.06x
EV / EBIT
-5.06x
Market cap
$112.4M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025